Therapeutic and Phytochemical Properties of Thymoquinone Derived from

Overview

Journal Curr Drug Res Rev

Publisher Bentham Science Publishers

Specialties Pharmacology
Psychiatry

Date 2023 Aug 22

PMID 37605475

Authors

Gaurav Tiwari

Monisha Gupta

Lalchand D Devhare

Ruchi Tiwari

Affiliations

Soon will be listed here.

Abstract

Background: , commonly known as black seed or black cumin, belongs to the family Ranunculaceae. It contains several phytoconstituents, Thymoquinone (TQ), thymol, thymohydroquinone, carvacrol, and dithymoquinone. TQ is the main phytoconstituent present in that is used as an herbal compound, and it is widely used as an antihypertensive, liver tonic, diuretic, digestive, anti-diarrheal, appetite stimulant, analgesic, and antibacterial agent, and in skin disorders.

Objective: The study focused on collecting data on the therapeutic or pharmacological activities of TQ present in seed.

Methods: Antidiabetic, anticancer, immunomodulator, analgesic, antimicrobial, anti-inflammatory, hepato-protective, renal protective, and antioxidant properties of TQ have been studied by various scientists.

Conclusion: TQ seems to have a variety of consequences on how infected cells behave at the cellular level.

Citing Articles

Thymoquinone: A comprehensive review of its potential role as a monotherapy for metabolic syndrome.

Ibrahim K, Hudu S, Jega A, Taha A, Yusuf A, Usman D Iran J Basic Med Sci. 2024; 27(10):1214-1227.

PMID: 39229585 PMC: 11366942. DOI: 10.22038/ijbms.2024.77203.16693.

References

Randhawa M, Alghamdi M . Anticancer activity of Nigella sativa (black seed) - a review. Am J Chin Med. 2011; 39(6):1075-91. DOI: 10.1142/S0192415X1100941X. View

Ahmad A, Husain A, Mujeeb M, Khan S, Najmi A, Siddique N . A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013; 3(5):337-52. PMC: 3642442. DOI: 10.1016/S2221-1691(13)60075-1. View

Woo C, Kumar A, Sethi G, Tan K . Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol. 2011; 83(4):443-51. DOI: 10.1016/j.bcp.2011.09.029. View

AbuKhader M . Thymoquinone in the clinical treatment of cancer: Fact or fiction?. Pharmacogn Rev. 2013; 7(14):117-20. PMC: 3841989. DOI: 10.4103/0973-7847.120509. View

Schneider-Stock R, Fakhoury I, Zaki A, El-Baba C, Gali-Muhtasib H . Thymoquinone: fifty years of success in the battle against cancer models. Drug Discov Today. 2013; 19(1):18-30. DOI: 10.1016/j.drudis.2013.08.021. View

Pari L, Sankaranarayanan C . Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 2009; 85(23-26):830-4. DOI: 10.1016/j.lfs.2009.10.021. View

El-Baba C, Mahadevan V, Fahlbusch F, S S, Rau T, Gali-Muhtasib H . Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer. Mol Cancer. 2014; 13:201. PMC: 4158125. DOI: 10.1186/1476-4598-13-201. View

Abdel-Fattah A, Matsumoto K, Watanabe H . Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol. 2000; 400(1):89-97. DOI: 10.1016/s0014-2999(00)00340-x. View

Hosseinzadeh H, Parvardeh S . Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine. 2004; 11(1):56-64. DOI: 10.1078/0944-7113-00376. View

10.

Hadad G, Abdel Salam R, Soliman R, Mesbah M . High-performance liquid chromatography quantification of principal antioxidants in black seed (Nigella sativa L.) phytopharmaceuticals. J AOAC Int. 2012; 95(4):1043-7. DOI: 10.5740/jaoacint.11-207. View

11.

Sultan M, Butt M, Ahmad R, Pasha I, Ahmad A, Qayyum M . Supplementation of Nigella sativa fixed and essential oil mediates potassium bromate induced oxidative stress and multiple organ toxicity. Pak J Pharm Sci. 2011; 25(1):175-81. View

12.

Coussens L, Werb Z . Inflammation and cancer. Nature. 2002; 420(6917):860-7. PMC: 2803035. DOI: 10.1038/nature01322. View

13.

Lefkowitz D, Gelderman M, Fuhrmann S, Graham S, Starnes 3rd J, Lefkowitz S . Neutrophilic myeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis. Clin Immunol. 1999; 91(2):145-55. DOI: 10.1006/clim.1999.4696. View

14.

Majdalawieh A, Ro H . Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages. Mediators Inflamm. 2010; 2010:823821. PMC: 2855089. DOI: 10.1155/2010/823821. View

15.

Kalamegam G, Alfakeeh S, Bahmaid A, AlHuwait E, Gari M, Abbas M . Evaluation of the Anti-inflammatory Effects of Thymoquinone in Osteoarthritis and Analysis of Inter-Related Pathways in Age-Related Degenerative Diseases. Front Cell Dev Biol. 2020; 8:646. PMC: 7391788. DOI: 10.3389/fcell.2020.00646. View

16.

Hossen M, Yang W, Kim D, Aravinthan A, Kim J, Cho J . Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities. Sci Rep. 2017; 7:42995. PMC: 5316937. DOI: 10.1038/srep42995. View

17.

Al Wafai R . Nigella sativa and thymoquinone suppress cyclooxygenase-2 and oxidative stress in pancreatic tissue of streptozotocin-induced diabetic rats. Pancreas. 2013; 42(5):841-9. DOI: 10.1097/MPA.0b013e318279ac1c. View

18.

Allemailem K, Alnuqaydan A, Almatroudi A, Alrumaihi F, Aljaghwani A, Khalilullah H . Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant . Pharmaceutics. 2021; 13(5). PMC: 8151670. DOI: 10.3390/pharmaceutics13050677. View

19.

Lu C, Soria J, Tang X, Xu X, Wang L, Mao L . Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers. J Clin Oncol. 2004; 22(22):4575-83. DOI: 10.1200/JCO.2004.01.091. View

20.

Cascinu S, Scartozzi M, Carbonari G, Pierantoni C, Verdecchia L, Mariani C . COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin. Am J Clin Oncol. 2007; 30(5):526-30. DOI: 10.1097/COC.0b013e318054675c. View